Article
Phosphoglucomutase Is an in Vivo Lithium Target in Yeast
1 Oct 2001
Abstract excerpt
Lithium is a drug frequently used in the treatment of manic depressive disorder. We have observed that the yeast Saccharomyces cerevisiae is very sensitive to lithium when growing in galactose medium. In this work we show that lithium inhibits with high affinity yeast (IC50 approximately 0.2 mm) and human (IC50 approximately 1.5 mm) phosphoglucomutase, the enzyme that catalyzes the reversible conversion of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
